New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

Links shared publicly online about this topic.

306
total visits

New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

A real-world study evaluating the safety of GARDASIL among 189,629 females in California found no serious adverse events related to vaccination, no safety signals for any health event resulting in an emergency room visit or hospitalization and no safety signals associated with pre-specified autoimmune conditions or pregnancy outcomes.

View full resource at news-medical.net

Tags: Wart, STD, HPV, Cervical Cancer Prevention, Vaccine, HPV Vaccine, Gardasil, Safety